Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16039738rdf:typepubmed:Citationlld:pubmed
pubmed-article:16039738lifeskim:mentionsumls-concept:C1533585lld:lifeskim
pubmed-article:16039738lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:16039738lifeskim:mentionsumls-concept:C0003069lld:lifeskim
pubmed-article:16039738lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:16039738lifeskim:mentionsumls-concept:C0234421lld:lifeskim
pubmed-article:16039738lifeskim:mentionsumls-concept:C0037494lld:lifeskim
pubmed-article:16039738lifeskim:mentionsumls-concept:C0184522lld:lifeskim
pubmed-article:16039738lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:16039738lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:16039738lifeskim:mentionsumls-concept:C0205099lld:lifeskim
pubmed-article:16039738lifeskim:mentionsumls-concept:C1708715lld:lifeskim
pubmed-article:16039738lifeskim:mentionsumls-concept:C2346689lld:lifeskim
pubmed-article:16039738lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:16039738lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:16039738lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:16039738pubmed:issue2lld:pubmed
pubmed-article:16039738pubmed:dateCreated2005-9-5lld:pubmed
pubmed-article:16039738pubmed:abstractTextThe present study is an investigation of the responses of the cardiovascular system and Fos expression to intracerebroventricular (i.c.v.) administration of hypertonic saline (HS) in conscious arginine vasopressin (AVP)-overexpressing transgenic (Tg) and control rats. Central HS (0.3, 0.67, or 1.0M NaCl, 1 microl/min for 20 min) significantly increased the mean arterial blood pressure (MABP) and Fos-like immunoreactivity (FLI) in the paraventricular nucleus (PVN) and supraoptic nucleus (SON) of the hypothalamus, the area postrema (AP), the median preoptic nucleus (MnPO), and the organum vasculosum laminae terminalis (OVLT) in both Tg and control rats. The changes in MABP and FLI were significantly larger in Tg rats than in control rats. i.c.v. pretreatment with the AVP V1 receptor antagonist, OPC-21268, blocked the increase in MABP and significantly decreased the Fos expression in the PVN (posterior magnocellular (pm) component) induced by 0.3 M HS in the Tg rats. The present study demonstrates an increased responsiveness to i.c.v. administration of HS in AVP Tg rats, suggesting the relationship between the vasopressinergic drive and central cardiovascular response via, at least in part, the V1 receptor in the PVN magnocellular neurons.lld:pubmed
pubmed-article:16039738pubmed:languageenglld:pubmed
pubmed-article:16039738pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16039738pubmed:citationSubsetIMlld:pubmed
pubmed-article:16039738pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16039738pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16039738pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16039738pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16039738pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16039738pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16039738pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16039738pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16039738pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16039738pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16039738pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16039738pubmed:statusMEDLINElld:pubmed
pubmed-article:16039738pubmed:monthOctlld:pubmed
pubmed-article:16039738pubmed:issn0168-0102lld:pubmed
pubmed-article:16039738pubmed:authorpubmed-author:KannanHiroshi...lld:pubmed
pubmed-article:16039738pubmed:authorpubmed-author:KatoKazuoKlld:pubmed
pubmed-article:16039738pubmed:authorpubmed-author:OisoYutakaYlld:pubmed
pubmed-article:16039738pubmed:authorpubmed-author:ChuChun-PingC...lld:pubmed
pubmed-article:16039738pubmed:authorpubmed-author:QiuDe-LaiDLlld:pubmed
pubmed-article:16039738pubmed:authorpubmed-author:JinQing-HuaQHlld:pubmed
pubmed-article:16039738pubmed:authorpubmed-author:YuNan-ShouNSlld:pubmed
pubmed-article:16039738pubmed:issnTypePrintlld:pubmed
pubmed-article:16039738pubmed:volume53lld:pubmed
pubmed-article:16039738pubmed:ownerNLMlld:pubmed
pubmed-article:16039738pubmed:authorsCompleteYlld:pubmed
pubmed-article:16039738pubmed:pagination147-55lld:pubmed
pubmed-article:16039738pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16039738pubmed:meshHeadingpubmed-meshheading:16039738...lld:pubmed
pubmed-article:16039738pubmed:meshHeadingpubmed-meshheading:16039738...lld:pubmed
pubmed-article:16039738pubmed:meshHeadingpubmed-meshheading:16039738...lld:pubmed
pubmed-article:16039738pubmed:meshHeadingpubmed-meshheading:16039738...lld:pubmed
pubmed-article:16039738pubmed:meshHeadingpubmed-meshheading:16039738...lld:pubmed
pubmed-article:16039738pubmed:meshHeadingpubmed-meshheading:16039738...lld:pubmed
pubmed-article:16039738pubmed:meshHeadingpubmed-meshheading:16039738...lld:pubmed
pubmed-article:16039738pubmed:meshHeadingpubmed-meshheading:16039738...lld:pubmed
pubmed-article:16039738pubmed:meshHeadingpubmed-meshheading:16039738...lld:pubmed
pubmed-article:16039738pubmed:meshHeadingpubmed-meshheading:16039738...lld:pubmed
pubmed-article:16039738pubmed:meshHeadingpubmed-meshheading:16039738...lld:pubmed
pubmed-article:16039738pubmed:meshHeadingpubmed-meshheading:16039738...lld:pubmed
pubmed-article:16039738pubmed:meshHeadingpubmed-meshheading:16039738...lld:pubmed
pubmed-article:16039738pubmed:meshHeadingpubmed-meshheading:16039738...lld:pubmed
pubmed-article:16039738pubmed:meshHeadingpubmed-meshheading:16039738...lld:pubmed
pubmed-article:16039738pubmed:meshHeadingpubmed-meshheading:16039738...lld:pubmed
pubmed-article:16039738pubmed:meshHeadingpubmed-meshheading:16039738...lld:pubmed
pubmed-article:16039738pubmed:meshHeadingpubmed-meshheading:16039738...lld:pubmed
pubmed-article:16039738pubmed:meshHeadingpubmed-meshheading:16039738...lld:pubmed
pubmed-article:16039738pubmed:meshHeadingpubmed-meshheading:16039738...lld:pubmed
pubmed-article:16039738pubmed:year2005lld:pubmed
pubmed-article:16039738pubmed:articleTitleEnhanced cardiovascular alteration and Fos expression induced by central salt loading in a conscious rat transgenic for the metallothionein-vasopressin fusion gene.lld:pubmed
pubmed-article:16039738pubmed:affiliationDepartment of Physiology, Miyazaki Medical College, University of Miyazaki, 5200 Kihara, Kiyotake-cho, Miyazaki-gun, Miyazaki 889 1692, Japan.lld:pubmed
pubmed-article:16039738pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16039738pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:16039738pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed